Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 9/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1857131 | 0.88 | HSP90AA1 (0.45) | HSP90AA1HSP90AB1ERBB2MTNR1AMTNR1B | |
| SCHEMBL1858046 | 0.86 | HSP90AA1 (0.50) | HSP90AA1HSP90AB1ERBB2F10POLB | |
| SCHEMBL14222613 | 0.82 | HSP90AA1 (0.33) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL1855723 | 0.81 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1ERBB2MTNR1AMTNR1B | |
| SCHEMBL30583198 | 0.81 | HSP90AA1 (0.69) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL4310551 | 0.81 | HSP90AA1 (0.69) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL1859066 | 0.80 | POLB (0.53) | HSP90AA1HSP90AB1POLB | |
| SCHEMBL1856028 | 0.79 | HSP90AA1 (0.50) | HSP90AA1HSP90AB1ERBB2 | |
| SCHEMBL4849398 | 0.79 | HSP90AA1 (0.48) | HSP90AA1HSP90AB1 | |
| SCHEMBL1670297 | 0.78 | HSP90AA1 (0.45) | HSP90AA1HSP90AB1ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323965-A1 | SMALL-MOLECULE HSP90 INHIBITORS | SLOAN KETTERING INST CANCER RES (US) | 2021-10-21 | — | — | US | disclosed |
| US-20200385389-A1 | SMALL-MOLECULE HSP90 INHIBITORS | SLOAN KETTERING INST CANCER RES (US) | 2020-12-10 | — | — | US | disclosed |
| US-10676476-B2 | Small-molecule HSP90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2020-06-09 | — | — | US | disclosed |
| US-20190023708-A1 | SMALL-MOLECULE HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2019-01-24 | — | — | US | disclosed |
| US-10167285-B2 | Small-molecule HSP90 inhibitors | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2019-01-01 | — | — | US | disclosed |
| US-10000494-B2 | Small-molecule Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2018-06-19 | — | — | US | disclosed |
| US-20170342073-A1 | SMALL-MOLECULE HSP90 INHIBITORS | MEMORIAL SLOAN KETTERING CANCER CENTER | 2017-11-30 | — | — | US | disclosed |
| US-9701678-B2 | Small-molecule HSP90 inhibitors | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2017-07-11 | — | — | US | disclosed |
| US-20160333014-A1 | SMALL-MOLECULE HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2016-11-17 | — | — | US | disclosed |
| US-9403828-B2 | Small-molecule Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2016-08-02 | — | — | US | disclosed |
| US-20140227183-A1 | SMALL-MOLECULE HSP90 INHIBITORS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2014-08-14 | — | — | US | disclosed |
| US-8703942-B2 | Small-molecule Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2014-04-22 | — | — | US | disclosed |
| US-20110312980-A1 | Small-molecule Hsp90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-12-22 | — | — | US | disclosed |
| US-20110104054-A1 | Small-Molecule HSP90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-05-05 | — | — | US | disclosed |
| US-7834181-B2 | Small-molecule Hsp90 inhibitors | SLAON-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2010-11-16 | — | — | US | disclosed |
| US-20080253965-A1 | Small-Molecule Hsp90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2008-10-16 | — | — | US | disclosed |
| WO-2006084030-A2 | SMALL-MOLECULE HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385389-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-20170342073-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90B1, HSP90AB2P, HSP90AB1 | HSP90AA1 4/4885HSP90AB1 3/4885ERBB2 711/4885 |
| US-10000494-B2 | Small-molecule Hsp90 inhibitors | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-20110104054-A1 | Small-Molecule HSP90 Inhibitors | HSP90AB2P, HSP90AB1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 2/4885ERBB2 297/4885 |
| US-20160333014-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-20190023708-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-10167285-B2 | Small-molecule HSP90 inhibitors | HSP90B1, HSP90AB2P, HSP90AB1 | HSP90AA1 4/4885HSP90AB1 3/4885ERBB2 764/4885 |
| US-20140227183-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90AB2P, HSP90AB1, HSP90B1 | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 404/4885 |
| US-20080253965-A1 | Small-Molecule Hsp90 Inhibitors | HSP90AB2P, HSP90AB1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 2/4885ERBB2 355/4885 |
| US-20210323965-A1 | SMALL-MOLECULE HSP90 INHIBITORS | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-10676476-B2 | Small-molecule HSP90 inhibitors | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
| US-20110312980-A1 | Small-molecule Hsp90 Inhibitors | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90AB1 2/4885ERBB2 2127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.